Fifth Global Cardio-Oncology Summit

October 3th, 4th. Opening Session: Welcome and opening remarks Plenary # 1: The evolving field of cardio-oncology: perspectives CARDIOTOXICITY Left Ventricular Dysfunction and HF In Cardio-Oncology Breast Cancer: Cancer Therapy Monitoring and Treatment Planning – What Should We Be Doing to Minimize Cardiotoxic Risk? Vascular toxicity associated with oncology treatments. CV Risk Alert in Heme Malignancies. Coronary Artery Disease in Oncology Patients Valvular disease Plenary # 2: Immunotherapy and Adverse Cardiac Events: How to recognize and manage New Scientific Advances in Cardio-Oncology Cardiac Imaging Research and Training Programs Advanced Heart Failure in Cancer Patients Cardiovascular Effects of Tyrosine Kinase Inhibitors for Various Solid and Liquid Tumors: Survivorship programs Physical Activity and Cancer Future of Cardio-Oncology How do we move forward?